Letters to the Editor

Curtis JC . Handbook for the assessment of dissociation—a clinical guide [review]. Can J Psychiatry 1997;42:978.

Kihlstrom JF . One hundred years of hysteria. In: Lynn SJ Rhue JW , editors. Dissociation, clinical and theoretical perspectives. New York: Guilford Press; 1994.

Nijenhuis ERS Spinhoven P van Dyck R van der Hart O Vanderlinden J. The development and psychometric characteristics of the Somatiform Dissociation Questionnaire (SDQ-20). J Nerv Ment Dis 1996;184:688–94.

Steinberg M. Structured clinical interview for DSM-IV dissociative disorders (SCID-D). Revised. Washington (DC): American Psychiatric Press; 1994.

Garfinkel P Bagby M Waring EM Dorian B. Boundary violations and personality traits among psychiatrists. Can J Psychiatry 1997;42:758–63.

Friedman AF Webb JT . Psychological assessment with the MMPI. Hillsdale (NJ): Lawrence Erlbaum Associates; 1989. 411 p.

Duckworth JC Anderson WP . MMPI, interpretation manual for counsellors and clinicians. 3rd ed. Muncie: AC; 1986. 388 p.

Hankins GC Vera MI Barnard GW Herkov MJ . Patient therapist sexual involvement: A review of clinical and research data. Bull Am Acad Psychiatry Law 1994;22:109–26.

Lazarus J. Ethical issues in doctor–patient sexual relationships. Psychiatr Clin North Am 1995;18:55–70.

Abel G Osborn C Clark F. Cognitive-behavioral treatment for professional sexual misconduct. Psychiatric Annals 1995;25:106–12.

Voruganti LNP Heslegrave RJ Awad AG . Neurocognitive correlates of positive and negative syndromes in schizophrenia. Can J Psychiatry 1997;42:1066–71.

Stip E Lussier I. The heterogeneity of memory dysfunction in schizophrenia. Can J Psychiatry 1996;41(1 Suppl):14S–20S.

Lussier I Stip E Coyette F. Explicit and implicit memory functioning in first episode and chronic schizophrenic patients, in comparison to brain damaged amnesic patients. Schizophr Res. Forthcoming.

Harvey PD Keefe RSE . Cognitive impairment in schizophrenia and implications of atypical neuroleptic treatment. CNS Spectrums 1997;2:1–11.

Bilder RM . Neurocognitive impairment in schizophrenia and how it affects treatment options. Can J Psychiatry 1997;42:255–64.

Selzer JA Lieberman JA . Schizophrenia and substance abuse. In: Powochik P Schulz Sc , editors. Psychiatr Clin North Am 1993;16:401–18.

DeQuardo JR Carpenter CF Tandon R. Patterns of substance abuse in schizophrenia: Nature and significance. Journal Name 1994;28:267–75.

Buckley P Thompson PA Way L Meltzer HY . Substance aluse and clozapine treatment. J Clin Psychiatry 1994;55:9(Suppl B);114–6.

Albanese MJ Khantzian EJ Murphy SL Green AI . Decreased substance abuse in chronically psychotic patients treated with clozapine. Am J Psychiatry 1994;151:780–1.

Marcus P Snyder R. Reduction of comorbid substance abuse with clozapine. Am J Psychiatry 1995;152:959.

Purdon SE Snaterse M. Selective serotonin reuptake inhibitor modulation of clozapine effects on cognition in schizophrenia [letter]. Can J Psychiatry 1998;43:84–5.

Fischer V Vogels B Maurer G Tynes R. The antipsychotic clozapine is metabolized by the polymorphic human microsmal and recombination cytochrome P450 2D6. J Pharmacol Exp Titer 1992;260:1355–60.

de Leon J Wedlund P Ehlers R Josiassen R Cooper T Simpson G. Cytochome p450–2D6 (CYP2D6) genotype: Relationship with clozapine and haloperidol metabolism. Biol Psychiatry 1996;39:591.

Bertilsson L Carrillo JA Dahl MI Llerena A Alm C Bondesson U , and others. Clozapine disposition covaries with CYP 1A2 activity determined by a caffeine test. Br J Clin Pharmacol 1994;38:71–3.

Jann M Grimsley S Gray E Chang W. Pharmacokinetics and pharmacodynamics of clozapine. Clin Pharmacokinet 1993;24:161–76.

Pirmohamed M Williams D Madden S Templeton E Park BK . Metabolism and bioactivation of clozapine by human liver in vitro. J Pharmacol Exp Ther 1995;275:984–90.

Taylor D. Pharmacokinetic interaction involving clozapine. Br J Psychiatry 1997;17:109–12.

Cenorrino F Baldessarini RJ Frankenburg FR Kando J Volicelli SA Flood JG . Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors. Am J Psychiatry 1996;153:820–2.

Chong SA Tan CH Lee HS . Worsening of psychosis with clozapine and selective serotonin reuptake inhibitor combination: Two case reports. J Clin Psychopharmacol 1997;17:68–9.

von Molte LL Greenblatt DJ Cotreau-Bibbo MM Hannatz JS Shader RI . Inhibitors of alprazolam metabolism in vitro: Effect of serotonin reuptake inhibitor antidepressants, ketoconazole and quinidine. Br J Clin Pharmacol 1994;38:23–31.

Parikh S Lin E Lesage AD . Mental health treatments in Ontario: Selective comparisons between primary care and specialty sectors. Can J Psychiatry 1997;42;929–34.

Boyle MH Offord DR Campbell D Catlin G Goering P Lin E , and others. Mental health supplement to the Ontario Health Survey. Can J Psychiatry 1996;41;549–58.

Paris J. Personality disorders: Psychiatry's stepchildren [editorial]. Can J Psychiatry 1998;43:135.

Bland RC Newman SC Orn H. Help-seeking for psychiatric disorders Can J Psychiatry 1997;42:935–42.

Bland RC Newman SC Orn H. Help-seeking for psychiatric disorders. Can J Psychiatry 1997;42:935–42.

Parikh S Lin E Lesage AD . Mental health treatments in Ontario: Selective comparisons between primary care and specialty sectors. Can J Psychiatry 1997;42:929–34.

Boyle MH Offord DR Campbell D Catlin G Goering P Lin E , and others. Mental health supplement to the Ontario Health Survey: Methodology. Can J Psychiatry 1996;41:549–58.

Guyenet PG Stornetta RL Riley T Norton FR Rosin DL Lynch KR . Alpha2A-adrenergic receptors are present in lower brainstem catecholaminergic and serotonergic neurons innervating spinal cord. Brain Res 1994;638:285–94.

Veith R Lewis N Linares OA , and others. Sympathetic nervous system activity in major depression. Arch Gen Psychiatry 1994;51:411–22.

Charney DS Price LH Heninger GR . Desipramine–yohimbine combination treatment of refractory depression implications for the beta-adrenergic receptor hypothesis of antidepressant action. Arch Gen Psychiatry 1986;43:1155–61.

Schmauss M Laakmann G Dieterle D. Effects of alpha 2-receptor blockade in addition to tricyclic antidepressants in therapy-resistant depression. J Clin Psychopharmacol 1988;8:108–11.

Richelson E. Pharmacokinetic drug interactions of new antidepressants: A review of the effects on the metabolism of other drugs. Mayo Clinic Proceedings 1997;72:835–47.